ARTICLE | Preclinical News

Moderna, Novavax among biotechs working on novel virus -- but vaccine at least a year out

January 22, 2020 1:02 AM UTC
Updated on Mar 27, 2020 at 2:24 AM UTC

At least four groups have started to develop vaccines to protect against the 2019 Novel Coronavirus (2019-nCoV) that was first detected in Wuhan, China.

Among companies working on a vaccine, Moderna Inc. (NASDAQ:MRNA) has partnered with NIH, while Novavax Inc. (NASDAQ:NVAX) shares rose sharply Tuesday on its development plans...